Valuable Informational/CE Sessions at Benefest 2011
Concurrent 1-Hour Sessions ongoing at Benefest 2011 – Spetember 28th. Check out our full schedule of events and register today!
Advising High Deductible Clients I – Pharmaceutical Benefits (1 MA CE approved – #C95455)
Presenter: Gary Fradin , President of Health InsuranceCE
As health plans shift to higher deductibles with narrower networks, consumers take on more responsibility to shop for their own medical care. This course introduces brokers to some issues related to pharmaceutical benefits, including disease risk data, Rx benefit data and Rx risk data. It also introduces brokers to fundamental medical statistics that they can share with their clients about disease risks and intervention outcomes.
Considerations for New Reimbursement Model (1 MA CE approved #C96200)
Presenters: Mim Minichiello, Senior Partner, EBS Capstone
John Donlan, Vice President of Managed Care, Steward Health Care System, LLC
Chief Operating Officer, Steward Health Care Network, Inc.
Private Payer reimbursements have traditionally been based on several models: fee for service, case rates and capitation. All three have unintended consequences in our health care system where cost containment is a major part of the health care reform discussion. This one hour presentation will touch upon the impact of hospital based market forces, the cost and control of medical care and the shared interplay of health plans, providers and ancillary providers in driving costs and sharing risks.
New Insights on Vision Benefits
Presenter: Laura Waldo: Director, Account Management,
This one hour workshop will focus on the growing ophthalmic market and the consumer trends feeding this growth. What is the importance of a vision benefit plan and how is this benefit so important? Vision problems are the 2nd most prevalent health problem in the country and the cost of ocular care, overall, are in the billions.
Advising High Deductible Clients II: Screening Benefits(1 MA CE approved – # C95456)
Presenter: Gary Fradin, President of Health InsuranceCE, LLC
As health plans shift to higher deductibles with narrower networks, consumers take on more responsibility to shop for their own medical care. This course introduces brokers to some data sources about disease risks and screening tests. Specifically, it discusses outcome measures – including both benefits and risk – from mamography, prostate specific antigen tests and other commonly administered texts. This course also reviews some introductory medical statistics so brokers have a better understanding of reporting methodologies.
Value Based Benefit Design – VBBD: An Innovative Benefit Strategy links Quality & Cost (1 MA CE approved – #C96242)
Presenter: F. Randy Vogenberg, RPh, PhD, Principal, Institute for Integrated Healthcare and Executive Director, Biologic Finance and Access Council,
A major impact of the Patient Protection and Affordable Care Act (PPACA) on groups depends on the type of group coverage and premiums current policy holders have or don’t have that will be the cost drivers in implementing and meeting the PPACA requirements. What constitutes grandfathered plans? What changes will occur in the rating practices of small groups? What group policy decisions will have the most impact on cost? How will state policies, federal tax credits and MCC frame the ongoing cost containment efforts in the Commonwealth’s group health benefit plans? Session sponsored by 
Social Media and Broker Branding: How to Boost Productivity
Presenter: Palmer Reuther, Senior VP at Racepoint Group
Social media can empower you and improve your ability to do business and provide your clients services. A major concern with this popular social tool is how to measure and identify key aspects and effectiveness.
